Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine-specific demethylase 5A (KDM5A) is a nuclear enzyme that removes methyl groups from methylated lysine 4 of histone H3, playing crucial roles in gene regulation and cell differentiation. It has been implicated in cancer development and is a member of the KDM5/JARID1 family. KDM5A regulates gene transcription, influences mitochondrial function, and interacts with retinoblastoma protein (pRB). Its inhibition has shown promise in overriding differentiation blocks in cancer cells.
Inhibition of demethylase activity, disruption of protein-protein interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine-specific demethylase 5A (KDM5A).